Gold Bull 48 , 147152 (2015)
Your provider will discuss what is realistic for your situation during consultation, based on your history and your labs rather than on an average
However, Wegovy tablets still offer meaningful weight loss and are likely to appeal strongly to people who dislike needles, feel uncomfortable self-injecting, or would simply prefer the convenience of a daily tablet
Yes, in 2026, Health Canada has so far approved two generic semaglutide products for the treatment of type 2 diabetes
Tirzepatide is generally considered for adults with a BMI in the overweight or obese range, especially when they also have weightrelated conditions like prediabetes, type 2 diabetes, high blood pressure, or high cholesterol
An integrative approach focused on the intestinal microbiota offers new prospects for modulating these risk factors